A065170 Stock Overview
BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
BL Pharmtech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩485.00 |
| 52 Week High | ₩930.00 |
| 52 Week Low | ₩322.00 |
| Beta | 0.84 |
| 1 Month Change | 0.21% |
| 3 Month Change | 43.49% |
| 1 Year Change | -26.40% |
| 3 Year Change | -69.69% |
| 5 Year Change | -76.96% |
| Change since IPO | -89.53% |
Recent News & Updates
Shareholder Returns
| A065170 | KR Personal Products | KR Market | |
|---|---|---|---|
| 7D | 3.2% | -0.7% | -0.4% |
| 1Y | -26.4% | -2.9% | 4.5% |
Return vs Industry: A065170 underperformed the KR Personal Products industry which returned -2.9% over the past year.
Return vs Market: A065170 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
| A065170 volatility | |
|---|---|
| A065170 Average Weekly Movement | 11.2% |
| Personal Products Industry Average Movement | 5.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A065170's share price has been volatile over the past 3 months.
Volatility Over Time: A065170's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 18 | Hyo-Lim Lee | www.blpharmtech.com |
BL Pharmtech Corp. manufactures, retails, imports, and exports health functional foods in South Korea. It is also involved in biotechnology business, as well as manufacture of cosmetics. The company was formerly known as Next BT Co., Ltd.
BL Pharmtech Corp. Fundamentals Summary
| A065170 fundamental statistics | |
|---|---|
| Market cap | ₩43.15b |
| Earnings (TTM) | -₩14.10b |
| Revenue (TTM) | ₩24.53b |
1.8x
P/S Ratio-3.1x
P/E RatioIs A065170 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A065170 income statement (TTM) | |
|---|---|
| Revenue | ₩24.53b |
| Cost of Revenue | ₩10.96b |
| Gross Profit | ₩13.56b |
| Other Expenses | ₩27.66b |
| Earnings | -₩14.10b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -158.49 |
| Gross Margin | 55.29% |
| Net Profit Margin | -57.49% |
| Debt/Equity Ratio | 11.8% |
How did A065170 perform over the long term?
See historical performance and comparison